Congenital diaphragmatic hernia medical therapy: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by one other user not shown)
Line 9: Line 9:
==Medical Therapy==
==Medical Therapy==


===Antenatal  Management <ref name="pmid32310536">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=32310536 | doi= | pmc= | url= }}</ref>===
===Antenatal  Management<ref name="pmid32310536">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=32310536 | doi= | pmc= | url= }}</ref>===


*Close monitoring to assess for fetal well-being; [[fetal therapy]] may be offered to eligible patients which involves occlusion of the fetal trachea at 26-30 weeks of gestation which allows fluid accumulation in the lung and its stretching. This results in release of [[surfactant]] but a potentially increased risk of [[preterm delivery]]. Post-natal CDH repair is still required. <ref name="pmid23378478">{{cite journal| author=Haroon J, Chamberlain RS| title=An evidence-based review of the current treatment of congenital diaphragmatic hernia. | journal=Clin Pediatr (Phila) | year= 2013 | volume= 52 | issue= 2 | pages= 115-24 | pmid=23378478 | doi=10.1177/0009922812472249 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23378478  }}</ref>
*Close monitoring to assess for fetal well-being; [[fetal therapy]] may be offered to eligible patients which involves occlusion of the fetal trachea at 26-30 weeks of gestation which allows fluid accumulation in the lung and its stretching. This results in release of [[surfactant]] but a potentially increased risk of [[preterm delivery]]. Post-natal CDH repair is still required.<ref name="pmid23378478">{{cite journal| author=Haroon J, Chamberlain RS| title=An evidence-based review of the current treatment of congenital diaphragmatic hernia. | journal=Clin Pediatr (Phila) | year= 2013 | volume= 52 | issue= 2 | pages= 115-24 | pmid=23378478 | doi=10.1177/0009922812472249 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23378478  }}</ref>


===Postnatal  Management <ref name="pmid323105362">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=32310536 | doi= | pmc= | url= }}</ref>===
===Postnatal  Management<ref name="pmid323105362">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=32310536 | doi= | pmc= | url= }}</ref>===


*Ensure delivery is not before 37 weeks, preferably at 39-40 weeks
*Ensure delivery is not before 37 weeks, preferably at 39-40 weeks
*[[Extracorporeal membrane oxygenation|Extracorporeal membrane oxygenation (ECMO)]] therapy has been used as part of the treatment strategy at some hospitals. <ref name="pmid17706494">{{cite journal |author=Tiruvoipati R, Vinogradova Y, Faulkner G, Sosnowski AW, Firmin RK, Peek GJ |title=Predictors of outcome in patients with congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation |journal=J. Pediatr. Surg. |volume=42 |issue=8 |pages=1345–50 |year=2007 |pmid=17706494 |doi=10.1016/j.jpedsurg.2007.03.031}}</ref><ref name="pmid17637787">{{cite journal |author=Logan JW, Rice HE, Goldberg RN, Cotten CM |title=Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies |journal=Journal of perinatology : official journal of the California Perinatal Association |volume=27 |issue=9 |pages=535–49 |year=2007 |pmid=17637787 |doi=10.1038/sj.jp.7211794}}</ref>
*[[Extracorporeal membrane oxygenation|Extracorporeal membrane oxygenation (ECMO)]] therapy has been used as part of the treatment strategy at some hospitals.<ref name="pmid17706494">{{cite journal |author=Tiruvoipati R, Vinogradova Y, Faulkner G, Sosnowski AW, Firmin RK, Peek GJ |title=Predictors of outcome in patients with congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation |journal=J. Pediatr. Surg. |volume=42 |issue=8 |pages=1345–50 |year=2007 |pmid=17706494 |doi=10.1016/j.jpedsurg.2007.03.031}}</ref><ref name="pmid17637787">{{cite journal |author=Logan JW, Rice HE, Goldberg RN, Cotten CM |title=Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies |journal=Journal of perinatology : official journal of the California Perinatal Association |volume=27 |issue=9 |pages=535–49 |year=2007 |pmid=17637787 |doi=10.1038/sj.jp.7211794}}</ref>


====Delivery Room Management====
====Delivery Room Management====
Line 45: Line 45:
*Adequate ventilation and oxygenation
*Adequate ventilation and oxygenation
*[[Vasopressors]]
*[[Vasopressors]]
*Inhaled [[nitric oxide]] ([[vasodilator]]) <ref name="pmid26463502">{{cite journal| author=Puligandla PS, Grabowski J, Austin M, Hedrick H, Renaud E, Arnold M | display-authors=etal| title=Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee. | journal=J Pediatr Surg | year= 2015 | volume= 50 | issue= 11 | pages= 1958-70 | pmid=26463502 | doi=10.1016/j.jpedsurg.2015.09.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26463502  }}</ref>
*Inhaled [[nitric oxide]] ([[vasodilator]])<ref name="pmid26463502">{{cite journal| author=Puligandla PS, Grabowski J, Austin M, Hedrick H, Renaud E, Arnold M | display-authors=etal| title=Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee. | journal=J Pediatr Surg | year= 2015 | volume= 50 | issue= 11 | pages= 1958-70 | pmid=26463502 | doi=10.1016/j.jpedsurg.2015.09.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26463502  }}</ref>
*Other drugs: [[sildenafil]], [[bosentan]], [[Alprostadil|PGE1]], [[Prostacyclin|PGI2]]
*Other drugs: [[sildenafil]], [[bosentan]], [[Alprostadil|PGE1]], [[Prostacyclin|PGI2]]


Line 51: Line 51:
{{Reflist|2}}
{{Reflist|2}}


[[Category:needs english review]]
[[Category:Up to Date]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]

Latest revision as of 01:37, 7 August 2022

Congenital diaphragmatic hernia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital diaphragmatic hernia from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Congenital diaphragmatic hernia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital diaphragmatic hernia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital diaphragmatic hernia medical therapy

CDC on Congenital diaphragmatic hernia medical therapy

Congenital diaphragmatic hernia medical therapy in the news

Blogs on Congenital diaphragmatic hernia medical therapy

Directions to Hospitals Treating Congenital diaphragmatic hernia

Risk calculators and risk factors for Congenital diaphragmatic hernia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S

Overview

Medical therapy can be subdivided according to antenatal and postnatal management. Antenatal management focuses on close monitoring. Fetal therapy may be an option for eligible patients with resultant fetal tracheal occlusion performed at 26-30 weeks to allow increased surfactant formation. Postnatal management primarily focuses on preventing birth before 37 weeks of gestation, as these neonates have been shown to have worse outcomes comparatively. Other postnatal options include the use of ECMO, the use of a nasogastric tube and intubation where required as well as maintaining adequate ventilation and oxygenation. Medications that may be helpful in reducing pulmonary hypertension include inhaled nitric oxide, sildenafil, bosentan, PGE1, and PGI2.

Medical Therapy

Antenatal Management[1]

  • Close monitoring to assess for fetal well-being; fetal therapy may be offered to eligible patients which involves occlusion of the fetal trachea at 26-30 weeks of gestation which allows fluid accumulation in the lung and its stretching. This results in release of surfactant but a potentially increased risk of preterm delivery. Post-natal CDH repair is still required.[2]

Postnatal Management[3]

Delivery Room Management

Target Values for Pulmonary Ventilation
Parameter Value
Pre-ductal saturation 85%-95%
PIP < 25 cm H2O
PEEP 3-5 cm H2O
PCO2 45-60 mmHg

Management of Pulmonary Hypertension

References

  1. "StatPearls".   ( ). 2022:  . PMID 32310536 Check |pmid= value (help).
  2. Haroon J, Chamberlain RS (2013). "An evidence-based review of the current treatment of congenital diaphragmatic hernia". Clin Pediatr (Phila). 52 (2): 115–24. doi:10.1177/0009922812472249. PMID 23378478.
  3. "StatPearls".   ( ). 2022:  . PMID 32310536 Check |pmid= value (help).
  4. Tiruvoipati R, Vinogradova Y, Faulkner G, Sosnowski AW, Firmin RK, Peek GJ (2007). "Predictors of outcome in patients with congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation". J. Pediatr. Surg. 42 (8): 1345–50. doi:10.1016/j.jpedsurg.2007.03.031. PMID 17706494.
  5. Logan JW, Rice HE, Goldberg RN, Cotten CM (2007). "Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies". Journal of perinatology : official journal of the California Perinatal Association. 27 (9): 535–49. doi:10.1038/sj.jp.7211794. PMID 17637787.
  6. Puligandla PS, Grabowski J, Austin M, Hedrick H, Renaud E, Arnold M; et al. (2015). "Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee". J Pediatr Surg. 50 (11): 1958–70. doi:10.1016/j.jpedsurg.2015.09.010. PMID 26463502.